MITOTIC-ACTIVITY AND PROGNOSIS IN PROSTATIC ADENOCARCINOMA

被引:33
作者
VESALAINEN, S
LIPPONEN, P
TALJA, M
SYRJANEN, K
机构
[1] UNIV KUOPIO,DEPT PATHOL,SF-70211 KUOPIO,FINLAND
[2] UNIV KUOPIO,DEPT SURG,SF-70210 KUOPIO,FINLAND
关键词
PROSTATIC ADENOCARCINOMA; GLEASON SCORE; MITOTIC INDEX; PROGRESSION; SURVIVAL;
D O I
10.1002/pros.2990260204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mitotic figures were quantitated by two different methods (number of mitotic figures in 10 high power fields, MI; number of mitotic figures/mm(2) of neoplastic epithelium, M/V) in a series of 303 prostatic adenocarcinomas, and the results were related to clinical and histological features as well as to prognosis. Gleason score and mitotic indices were significantly interrelated. Invasive T3-4 tumors showed higher mitosis counts than did the local ones, and metastasis at the time of diagnosis was related to mitotic indices as well. Progression and progression-free survival were related significantly to Gleason score and mitotic indices. In univariate survival analysis, T-category, M-category, Gleason score, MI, and M/V were significant prognostic factors. In multivariate analysis, independent predictors of survival were M-category, T-category, Gleason score, patient age, and the M/V index. If the Gleason score was not included, M/V included all the available prognostic information in T1-2MO carcinomas. The results show that, in addition to the conventional Gleason grading system, mitotic indices are useful prognostic parameters while evaluating the longterm prognosis in prostatic adenocarcinoma. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 26 条
[1]  
Baak J. P. A., 1983, MANUAL MORPHOMETRY D
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]  
EPSTEIN JI, 1984, CANCER, V54, P1133
[4]  
ESKELINEN M, 1991, EUR UROL, V19, P274
[5]   THE AREA OF CANCER IN TRANSURETHRAL RESECTION SPECIMENS AS A PROGNOSTIC INDICATOR IN CARCINOMA OF THE PROSTATE - A COMPUTER-ASSISTED MORPHOMETRIC STUDY [J].
FOUCAR, E ;
HAAKE, G ;
DALTON, L ;
PATHAK, DR ;
LUJAN, JP .
HUMAN PATHOLOGY, 1990, 21 (06) :586-592
[6]   EPIDERMAL GROWTH-FACTOR AND PROSTATIC-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY [J].
FOWLER, JE ;
LAU, JLT ;
GHOSH, L ;
MILLS, SE ;
MOUNZER, A .
JOURNAL OF UROLOGY, 1988, 139 (04) :857-861
[7]   HISTOLOGIC GRADING OF PRIMARY PROSTATIC-CANCER - A NEW APPROACH TO AN OLD PROBLEM [J].
GAETA, JF ;
ASIRWATHAM, JE ;
MILLER, G ;
MURPHY, GP .
JOURNAL OF UROLOGY, 1980, 123 (05) :689-693
[8]  
Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171
[9]   PROGNOSIS OF OVARIAN CARCINOMAS - PREDICTION BY HISTOQUANTITATIVE METHODS [J].
HAAPASALO, H ;
COLLAN, Y ;
ATKIN, NB ;
PESONEN, E ;
SEPPA, A .
HISTOPATHOLOGY, 1989, 15 (02) :167-178
[10]   RELATIONSHIP OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN PROSTATIC CARCINOMAS TO VARIOUS CLINICAL-PARAMETERS [J].
HARPER, ME ;
GLYNNEJONES, E ;
GODDARD, L ;
WILSON, DW ;
MATENHELIA, SS ;
CONN, IG ;
PEELING, WB ;
GRIFFITHS, K .
PROSTATE, 1992, 20 (03) :243-253